Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies produced by a person’s immune system. ANCA testing detects and measures the amount of these autoantibodies in the blood. Two of the most common types or subsets of ANCA are the autoantibodies that target the proteins myeloperoxidase (MPO) and proteinase 3 (PR3).

The normal test result should be negative.

Positive ANCA, PR3, and/or MPO tests help to support a diagnosis of systemic autoimmune vasculitis and to distinguish between different types. However, to confirm a diagnosis, a biopsy of an affected site is often required.
Negative ANCA tests results mean it is unlikely that a person’s symptoms are due to an autoimmune vasculitis.

ANCA testing can be useful in evaluating patients with symptoms of an inflammatory bowel disease (IBD).
If atypical ANCA is positive and ASCA (anti-Saccharomyces cerevisiae antibodies) is negative, then it is likely that the person has ulcerative colitis (UC).

If atypical ANCA is negative and ASCA is positive, then it is likely that the person has Crohn disease (CD). A person who is negative for ANCA and/or ASCA may still have UC, CD, or another IBD.

* The contents of this HTQ Site are for informational and communicational purposes only. The information provided by HTQ, HTQ employees, others appearing on the Site at the invitation of HTQ, or other visitors to the Site is NOT a medical advice.The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the HTQ Site!